Patent details

EP3050576 Title: PEGYLATED RECOMBINANT HUMAN GROWTH HORMONE COMPOUNDS

Basic Information

Publication number:
EP3050576
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP161568522
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
PEGYLATED RECOMBINANT HUMAN GROWTH HORMONE COMPOUNDS
French Title of Invention:
HORMONE DE CROISSANCE HUMAINE RECOMBINANTE PEGYLÉE
German Title of Invention:
PEGYLIERTE REKOMBINANTE HUMANE WACHSTUMSHORMON-VERBINDUNGEN
SPC Number:

Dates

Filing date:
29/04/2009
Grant date:
31/03/2021
EP Publication Date:
03/08/2016
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
31/03/2021
EP B1 Publication Date:
31/03/2021
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
29/04/2029
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
24/03/2021
 
 

Name:
ASCENDIS PHARMA ENDOCRINOLOGY DIVISION A/S
Address:
Tuborg Boulevard 12, 2900 Hellerup, Denmark (DK)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
12/05/2021
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
Rasmussen, Grethe Nørskov
Address:
Denmark (DK)

2

Name:
Hersel, Ulrich
Address:
Germany (DE)

3

Name:
Kindermann, Susanne
Address:
Germany (DE)

4

Name:
Lessmann, Torben
Address:
Germany (DE)

5

Name:
Sprogøe, Kennett
Address:
Denmark (DK)

6

Name:
Rau, Harald
Address:
Germany (DE)

7

Name:
Wegge, Thomas
Address:
Germany (DE)

Priority

1

Priority Number:
08155408
Priority Date:
29/04/2008
Priority Country:
European Patent Office (EPO) (EP)

2

Priority Number:
08162865
Priority Date:
22/08/2008
Priority Country:
European Patent Office (EPO) (EP)

3

Priority Number:
08167289
Priority Date:
22/10/2008
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC classification:
A61K 38/27; A61P 1/04; A61P 1/16; A61P 3/04; A61P 5/06; A61P 9/00; A61P 11/00; A61P 13/12; A61P 15/08; A61P 19/02; A61P 21/00; A61P 25/24; A61P 29/00; A61P 31/18; A61P 35/00; A61P 37/06; A61P 39/06; A61P 43/00; A61K 47/60; A61K 47/65;

Publication

European Patent Bulletin

1

Issue number:
202113
Publication date:
31/03/2021
Description:
Grant (B1)

2

Issue number:
202118
Publication date:
05/05/2021
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
30/04/2026
Annual Fee Number:
18
Annual Fee Amount:
262 Euro
Expected Payer:
Last Annual Fee Payment Date:
17/04/2025
Last Annual Fee Paid Number:
17
Last Annual Fee Paid Amount:
246 Euro
Payer:
PAVIS PAYMENTS GMBH
Filing date Document type Number of pages
12/05/2021 Power Of Attorney 1
12/05/2021 Outgoing Correspondence 1